Renaissance Technologies (RenTech)'s LPCN Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC (Rentech)) currently holds 37,397 shares of Lipocine Inc. (LPCN) worth $300,298, representing 0.00% of the portfolio. First purchased in 2015-Q1, this long-term strategic position has been held for 35 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in LPCN, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2019, adding 76,029 shares. Largest reduction occurred in Q1 2020, reducing 95,656 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Lipocine (LPCN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Lipocine (LPCN) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +1,300 | Add 3.60% | 37,397 | $8.03 |
| Q3 2025 | +1,300 | Add 3.74% | 36,097 | $2.85 |
| Q2 2025 | -2,713 | Reduce 7.23% | 34,797 | $3.16 |
| Q1 2025 | +1,478 | Add 4.10% | 37,510 | $3.18 |
| Q4 2024 | -4,300 | Reduce 10.66% | 36,032 | $4.88 |
| Q3 2024 | +14,635 | Add 56.95% | 40,332 | $4.49 |
| Q2 2024 | +4,600 | Add 21.80% | 25,697 | $8.24 |
| Q1 2024 | +2,300 | Add 12.24% | 21,097 | $5.21 |
| Q4 2023 | +3,200 | Add 20.52% | 18,797 | $2.77 |
| Q3 2023 | +5,200 | Add 50.01% | 15,597 | $2.95 |
| Q2 2023 | -1,271 | Reduce 10.89% | 10,397 | $0.01 |
| Q1 2023 | +121 | Add 1.05% | 11,668 | $0.01 |
| Q4 2022 | -182 | Reduce 1.55% | 11,547 | $0.01 |
| Q3 2022 | +6,964 | Add 146.15% | 11,729 | $7.67 |
| Q2 2022 | +3,936 | Add 474.79% | 4,765 | $13.64 |
| Q1 2022 | +829 | New Buy | 829 | $22.92 |
| Q3 2020 | -18,594 | Sold Out | 0 | $0.00 |
| Q2 2020 | +2,411 | Add 14.90% | 18,594 | $21.40 |
| Q1 2020 | -95,656 | Reduce 85.53% | 16,183 | $8.16 |
| Q4 2019 | +76,029 | Add 212.31% | 111,839 | $6.55 |
| Q3 2019 | +6,654 | Add 22.82% | 35,810 | $47.78 |
| Q2 2019 | +5,232 | Add 21.87% | 29,156 | $33.17 |
| Q1 2019 | +12,065 | Add 101.74% | 23,924 | $39.25 |
| Q4 2018 | +3,906 | Add 49.11% | 11,859 | $22.09 |
| Q3 2018 | +1,724 | Add 27.68% | 7,953 | $23.51 |
| Q2 2018 | +1,411 | Add 29.29% | 6,229 | $22.15 |
| Q1 2018 | +4,818 | New Buy | 4,818 | $25.94 |
| Q4 2017 | -13,447 | Sold Out | 0 | $0.00 |
| Q3 2017 | +13,447 | New Buy | 13,447 | $67.52 |
| Q2 2016 | -1,129 | Sold Out | 0 | $0.00 |
| Q1 2016 | -9,412 | Reduce 89.29% | 1,129 | $172.72 |
| Q4 2015 | -3,559 | Reduce 25.24% | 10,541 | $219.81 |
| Q3 2015 | +3,285 | Add 30.37% | 14,100 | $201.13 |
| Q2 2015 | +9,356 | Add 641.26% | 10,815 | $145.91 |
| Q1 2015 | +1,459 | New Buy | 1,459 | $117.20 |
Renaissance Technologies (RenTech)'s Lipocine Investment FAQs
Renaissance Technologies (RenTech) first purchased Lipocine Inc. (LPCN) in Q1 2015, acquiring 1,459 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Lipocine Inc. (LPCN) for 35 quarters since Q1 2015.
Renaissance Technologies (RenTech)'s largest addition to Lipocine Inc. (LPCN) was in Q4 2019, adding 111,839 shares worth $732,000.
According to the latest 13F filing for Q4 2025, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC (Rentech), owns 37,397 shares of Lipocine Inc. (LPCN), valued at approximately $300,298.
As of the Q4 2025 filing, Lipocine Inc. (LPCN) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Lipocine Inc. (LPCN) was 111,839 shares, as reported at the end of Q4 2019.